BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 17550753)

  • 1. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
    Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
    Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
    Stuart EC; Scandlyn MJ; Rosengren RJ
    Life Sci; 2006 Nov; 79(25):2329-36. PubMed ID: 16945390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
    Nagle DG; Ferreira D; Zhou YD
    Phytochemistry; 2006 Sep; 67(17):1849-55. PubMed ID: 16876833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.
    Pan MH; Chiou YS; Wang YJ; Ho CT; Lin JK
    Food Funct; 2011 Feb; 2(2):101-10. PubMed ID: 21779554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
    Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
    Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
    Shimizu M; Adachi S; Masuda M; Kozawa O; Moriwaki H
    Mol Nutr Food Res; 2011 Jun; 55(6):832-43. PubMed ID: 21538846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of EGCG: a patent review.
    Chakrawarti L; Agrawal R; Dang S; Gupta S; Gabrani R
    Expert Opin Ther Pat; 2016 Aug; 26(8):907-16. PubMed ID: 27338088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.
    Khan N; Afaq F; Saleem M; Ahmad N; Mukhtar H
    Cancer Res; 2006 Mar; 66(5):2500-5. PubMed ID: 16510563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma.
    Liu X; Zhang DY; Zhang W; Zhao X; Yuan C; Ye F
    Nutr Cancer; 2011; 63(3):466-75. PubMed ID: 21391127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
    Lee MH; Han DW; Hyon SH; Park JC
    Apoptosis; 2011 Jan; 16(1):75-85. PubMed ID: 20963498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for cancer chemoprevention by green tea polyphenol EGCG.
    Tachibana H
    Forum Nutr; 2009; 61():156-169. PubMed ID: 19367120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro cytotoxicity of epigallocatechin gallate and tea extracts to cancerous and normal cells from the human oral cavity.
    Weisburg JH; Weissman DB; Sedaghat T; Babich H
    Basic Clin Pharmacol Toxicol; 2004 Oct; 95(4):191-200. PubMed ID: 15504155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.
    Singh BN; Shankar S; Srivastava RK
    Biochem Pharmacol; 2011 Dec; 82(12):1807-21. PubMed ID: 21827739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
    Rocha S; Generalov R; Pereira Mdo C; Peres I; Juzenas P; Coelho MA
    Nanomedicine (Lond); 2011 Jan; 6(1):79-87. PubMed ID: 21182420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
    Wang YC; Bachrach U
    Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple actions of EGCG, the main component of green tea].
    L'Allemain G
    Bull Cancer; 1999 Sep; 86(9):721-4. PubMed ID: 10519963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate.
    J Cell Biochem Suppl; 1996; 26():236-57. PubMed ID: 9154181
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.
    Suganuma M; Okabe S; Kai Y; Sueoka N; Sueoka E; Fujiki H
    Cancer Res; 1999 Jan; 59(1):44-7. PubMed ID: 9892181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate.
    Ahmad N; Cheng P; Mukhtar H
    Biochem Biophys Res Commun; 2000 Aug; 275(2):328-34. PubMed ID: 10964666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.